健康去哪儿
健趣网登录 关闭
还没有账号?立即注册

Continuity of Care and Use of Urgent Healthcare in Multimorbid Patients

Sponsor:
Collaborators:
Information provided by (Responsible Party):
Alexandre MALMARTEL,University of Paris 5 - Rene Descartes
October 2, 2018
October 5, 2018
October 5, 2018
January 15, 2019
January 15, 2020   (Final data collection date for primary outcome measure)
Continuity of care[ Time Frame: over the past 1year ]
Bice-Boxerman index, measuring continuity of care (from 0 to 1, 1 = good continuity of care)

care pathway[ Time Frame: over the past 1 year ]
the number of health care consultations with any physician (primary care, emergency department, hospitalisation), collected from the French national health insurance database

Same as current
  • global quality of life[ Time Frame: over the past 1 year ]
    EuroQol Health Questionnaire in 5 questions measuring quality of life by the EuroQol Group. (from 0 to 100, 100= good quality of life)
  • burden of traitement[ Time Frame: over the past 1 year ]
    Treatment Burden Questionnaire developped by VT Tran (from 0 to 130, 130 = treatments are a huge problem for the patient)
 

Continuity of Care and Use of Urgent Healthcare in Multimorbid Patients

Continuity of Care and Use of Urgent Healthcare in Multimorbid Patients

Chronic disease management is a public health problem that faces monitoring difficulties related to complex care pathways. This study will analyze the use of unscheduled or urgent care according to the continuity of care in multimorbid patients

The prevalence of chronic diseases in the population is increasing significantly. It represents a new challenge for doctors and health authorities. However, patients often have at least two chronic diseases. These are referred to as "multimorbid" patients, whose continuity of care has not been well studied to date. This observational study evaluates the association between the continuity of care in multimorbid patients seen in general practice and their use of urgent healthcare, their quality of life and their burden of treatment.
Observational
Allocation:
Intervention Model:
Intervention Model Description:
Masking: Observational
Masking Description:
Primary Purpose:
  • :
  • : multmorbid patients
    patients with 2 chronic diseases (medical conditions requiring management for more than 6 months)
 
Not yet recruiting
600
Same as current
June 15, 2020
January 15, 2020   (Final data collection date for primary outcome measure)
Inclusion Criteria: - over 18 years of age, seen in consultation in the office by an investigating doctor, with a follow-up for more than 12 months in the office, presenting at least two chronic disease , having given their written consent to participate in the study Exclusion Criteria: - seen at home - unable to respond (cognitive problems or language barrier)
Sexes Eligible for Study: All
18 Years and older   (Adult, Older Adult)
No
 
 
No
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Plan to Share IPD: No
Alexandre MALMARTEL,University of Paris 5 - Rene Descartes
University of Paris 5 - Rene Descartes
:
University of Paris 5 - Rene Descartes
October 2018

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP
请使用微信扫码报名